Xolair 150 MG/ML 1S
Ended Awarded
- Contract number
- SPE2DX25FKWBH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,705
Award facts
- Contract value 100% obligated
- $7,704.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,704.99 for Xolair 150 mg/ml by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a direct procurement with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Xolair is a biologic medication used primarily for moderate-to-severe allergic asthma and chronic idiopathic urticaria treatment. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing specialty medications and biologics to Department of Defense healthcare sites. The company's sustained contract performance across diverse pharmaceutical categories, including injectable medications, specialty treatments, and biologics, demonstrates its capacity to fulfill specialized medical supply requirements for military healthcare operations.
Quick answers
Who was awarded contract SPE2DX25FKWBH?
SPE2DX25FKWBH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25FKWBH worth?
The government has obligated $7,705 on SPE2DX25FKWBH.
Is contract SPE2DX25FKWBH an order under another contract?
Yes. SPE2DX25FKWBH is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKWBH competed?
The extent of competition for SPE2DX25FKWBH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award